Transcat, Inc.

NASDAQ:TRNS

Industrial - Distribution

Industrials
$100.12 +2.19%

+$2.00 today

Market cap
$941.61M
Beta
0.70
P/E (TTM)
150.2
EPS (TTM)
$0.62
52W Low $50.23High $94.76

Volume 0.11M

Average 0.16M

TRNS Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Transcat, Inc.NASDAQ: TRNS

Cash & Equivalents · Q4 FY2025 · quarter ended Mar 2026

Cash & equivalents rises 225.8% from a year ago

Cash & equivalents stood at $4.94M at the end of Q4 FY2025, up 225.8% from a year earlier and up 42.4% from the prior quarter. Over 3 fiscal years it compounded at +47.8% a year.

Context

  • Cash & equivalents amounted to 1.0% of total assets at the end of Q4 FY2025, up 0.6 pp from a year earlier.
  • Cash & equivalents increased in 2 of the last 3 fiscal years.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +225.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.94M+42.4% QoQ
Last fiscal yearMar 2026
$4.94M+225.8% YoY
Year agoMar 2025
$1.52M+225.8% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+225.8%——
1 year+225.8%——
3-year CAGR+47.8%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
4.94M USD
Year-over-year change
+225.8%
4-year CAGR
+37.2%

Cash & Equivalents vs competitors

How TRNS compares with its peers on the latest reported figures

  • TRNS's Mar 2026 cash & equivalents of $4.94M is the 10th highest of the 11 companies compared; the peer median is $142.97M.
  • Its year-over-year change of +225.8% is the highest of 11, against a peer median of +19.0%.
  • Cash & equivalents amounts to 1.0% of total assets for TRNS, versus a peer median of 5.4%.
TRNS Competitors Peer median
Cash & Equivalents for TRNS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BIOBio-Rad Laboratories, Inc.Jun 2026$517M +40.0%+7.0%5.0%
TICTIC Solutions, Inc.Jun 2026$362.42M +178.7%—8.4%
TECHBio-Techne CorporationSep 2026$350.04M +141.5%+13.6%13.3%
LABStandard BioTools Inc.Mar 2026$265.77M +76.1%+13.3%41.6%
NEONeoGenomics, Inc.Jun 2026$145.54M -5.9%-15.4%10.8%
QDELQuidelOrtho CorporationMar 2026$140.4M +10.5%-16.6%2.5%
MTDMettler-Toledo International Inc.Jun 2026$51.38M -16.9%-11.3%1.4%
BLFSBioLife Solutions, Inc.Mar 2026$22.82M -65.9%+19.3%5.7%
UFPTUFP Technologies, Inc.Jun 2026$9.05M -39.3%+65.8%1.3%
TRNSTranscat, Inc.Mar 2026$4.94M +225.8%+47.8%1.0%
TKNOAlpha Teknova, Inc.Mar 2026$4.31M +27.5%-48.1%4.4%
Peer median (excluding TRNS) $142.97M+19.0%+7.0%5.4%

Competitors are the stored peer set for TRNS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Cash & Equivalents1.4M1.53M19.65M1.52M4.94M
Short-term Investments0015.53M00
Net Receivables40.3M45.2M48.29M56.31M65.84M
Inventory12.71M16.93M17.42M14.48M13.71M
Other Current Assets03.94M4.28M5.7M7.97M
Total Current Assets59.7M67.6M105.16M78.01M92.46M
Property, Plant & Equipment (Net)37.47M43.94M55.77M74.37M57.8M
Goodwill65.07M69.36M105.59M176.93M218.19M
Intangible Assets14.69M13.8M19.99M54.78M77.71M
Long-term Investments000100K0
Tax Assets00000
Other Non-current Assets827K1.05M1.06M1.06M34.33M
Total Non-current Assets118.06M128.15M182.39M307.23M388.03M
Total Assets177.76M195.75M287.55M385.24M480.49M
Account Payables14.17M15.87M11.5M16.76M17.93M
Short-term Debt2.16M2.25M2.34M1.82M0
Tax Payables0736K3.74M654K0
Deferred Revenue00000
Other Current Liabilities11.38M1.13M620K1.14M21.7M
Total Current Liabilities27.71M28.32M33.5M34.04M39.63M
Long-term Debt46.29M46.87M1.82M30.89M99.88M
Deferred Tax Liabilities6.72M6.54M9.29M9.29M10.17M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.67M1.43M2.9M2.75M1.19M
Total Non-current Liabilities63.88M67.8M28.88M64.33M140.24M
Total Liabilities91.59M96.12M62.38M98.36M179.87M
Common Stock3.77M3.78M4.42M4.66M4.67M
Retained Earnings58.74M69.16M80.07M92.52M97.76M
Accumulated OCI(233K)(1.2M)(949K)(1.47M)(923K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity86.18M99.63M225.17M286.88M300.62M
Total Debt57.65M64.41M21.54M57.73M128.89M
Net Debt56.25M62.88M1.89M56.21M123.94M

Transcat, Inc.

NASDAQ:TRNS

Intrinsic Alpha fair value

Locked

Current Price

$100.12

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.